Overview

Evaluation of Preoperative N1539 in Total Knee Arthroplasty

Status:
Completed
Trial end date:
2019-05-21
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the effect of preoperative administration of N1539 on opioid consumption in subjects undergoing open unilateral total knee arthroplasty compared to placebo.
Phase:
Phase 3
Details
Lead Sponsor:
Recro Pharma, Inc.
Treatments:
Meloxicam